Developing an effective vaccine formulation using self-amplifying RNA and a nanoparticle emulsion

Vaccine Insights 2023; 2(10), 395–398

DOI: 10.18609/vac.2023.52

Published: 8 November
Amit Khandhar

Charlotte Barker, Editor, Vaccine Insightsspeaks to Amit Khandhar, Director of Formulations, HDT Bioabout creating a formulation that aims to address key challenges of RNA vaccines, including thermostability and reactogenicity.